Quest Diagnostics Incorporated (DGX)
NYSE
Closed
Aug 28, 2026
Day's Range
242.7452 wk Range
171.18Overview - DGX - Quest Diagnostics Incorporated
Key Statistics
Valuation
Enterprise Value
33.14B
P/E (Trailing)
‪25.90‬
P/E (Forward)
‪20.27‬
PEG Ratio
‪1.75‬
Price / Sales (TTM)
‪2.33‬
Price / Book
‪3.57‬
EV / EBITDA
‪14.62‬
Profitability
Gross Margin
‪33.74%‬
Profit Margin
‪9.18%‬
Operating Margin
‪15.24%‬
Return on Assets
‪6.40%‬
Return on Equity
‪14.60%‬
Ownership
Shares Outstanding
109.69M
Float
109.80M
Short % of Shares Outstanding
‪3.01%‬
Held by Insiders
‪0.44%‬
Held by Institutions
‪98.98%‬
Price stats
Beta
‪0.54‬
50-Day Avg
‪220.11‬
200-Day Avg
‪198.51‬
Dividends
Payout Ratio
‪26.11%‬
Frequency
Quarterly
Analyst Consensus
17 analysts
Average price target
‪$ 245.87‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DGX - Quest Diagnostics Incorporated
Peers - DGX - Quest Diagnostics Incorporated
Peer Comparison
Compared with companies in Diagnostics & Research listed on NYSE.
- DGXNYSEQuest Diagnostics Inc.27.04BMarket Cap+27.39%52-week change25.90P/E (Trailing)‪9.18%‬Profit Margin
- DHR.PR.ANYSEDanaher Corp1.29TMarket Cap—52-week change213.72P/E (Trailing)‪60.95%‬Profit Margin
- TMONYSEThermo Fisher Scientific Inc.226.94BMarket Cap+20.55%52-week change33.09P/E (Trailing)‪15.03%‬Profit Margin
- IQVNYSEIQVIA Holdings Inc.44.07BMarket Cap+29.91%52-week change33.77P/E (Trailing)‪8.09%‬Profit Margin
- ANYSEAgilent Technologies Inc.42.53BMarket Cap+15.07%52-week change29.88P/E (Trailing)‪19.53%‬Profit Margin
- WATNYSEWaters Corporation40.60BMarket Cap+25.18%52-week change104.17P/E (Trailing)‪3.58%‬Profit Margin
- DIDIANYSEState Street SPDR Dow Jones Industrial Average ETF Trust39.98BMarket Cap+14.81%52-week change22.04P/E (Trailing)—Profit Margin
Profile Summary - DGX - Quest Diagnostics Incorporated
About
Quest Diagnostics Inc. is a leading independent provider of diagnostic testing, information, and services in the United States. The company generates the majority of its revenue from clinical testing, anatomic pathology, esoteric testing, and substance abuse testing, conducted through a national network of…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
